% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • nidan7500 nidan7500 Jun 1, 2013 8:49 AM Flag

    Another 10+ point day suggested? Stay tuned.

    Just after 10 AM central -Monday:"(NASDAQ: ONXX) today announced that it will hold a conference call to discuss data presented at an ASCO plenary session from the DECISION study, a Phase 3 trial investigating the use of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine-refractory (RAI) differentiated thyroid cancer. The call will feature the principal investigator, Marcia Brose, M.D., Ph.D., Assistant Professor in the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania, and will include members of Onyx's management. "

    SortNewest  |  Oldest  |  Most Replied Expand all replies